These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18579209)

  • 41. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
    Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS
    Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
    Kempen JH; Gangaputra S; Daniel E; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Helzlsouer KJ
    Am J Ophthalmol; 2008 Dec; 146(6):802-12.e1. PubMed ID: 18579112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis.
    Jachens AW; Chu DS
    Am J Ophthalmol; 2008 Mar; 145(3):487-492. PubMed ID: 18282493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
    Kelly NK; Chattopadhyay A; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Cugley D; Lim LL; Suhler EB; Al-Dhibi HA; Ebert CD; Berlinberg EJ; Porco TC; Acharya NR;
    Ophthalmology; 2021 Sep; 128(9):1337-1345. PubMed ID: 33675850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
    Joshi L; Talat L; Yaganti S; Sandhu S; Taylor SR; Wakefield D; McCluskey P; Lightman S
    Ophthalmology; 2014 May; 121(5):1119-24. PubMed ID: 24433970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
    Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
    Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate?
    Jabs DA
    JAMA Ophthalmol; 2019 Dec; 137(12):1449-1451. PubMed ID: 31503274
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH; Comer M; Lightman S
    Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine for ocular inflammatory diseases.
    Kaçmaz RO; Kempen JH; Newcomb C; Daniel E; Gangaputra S; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Foster CS
    Ophthalmology; 2010 Mar; 117(3):576-84. PubMed ID: 20031223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.
    Kong CL; Kelly NK; Sundararajan M; Rathinam SR; Gonzales JA; Thundikandy R; Vedhanayaki R; Kanakath A; Murugan B; Doan T; Goldstein D; Al-Dhibi HA; Acharya NR
    Ocul Immunol Inflamm; 2022 Jan; 30(1):198-202. PubMed ID: 32779952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.